Particularly, PARP-1 inhibition improves functional, biochemical, and morphometric parameters in an in vivo allergen-induced asthma-like reaction model (Lucarini et al., 2014) and in a bleomycin-induced pulmonary fibrosis model (Lucarini et al., 2017). The gene discussed is PARP1; the disease is asthma.